Overactive Bladder
494
32
36
309
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
127 trials with published results (26%)
Research Maturity
309 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
9.5%
47 terminated out of 494 trials
86.8%
+0.3% vs benchmark
29%
145 trials in Phase 3/4
41%
127 of 309 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 309 completed trials
Clinical Trials (494)
Add-On ZIDA Sock Therapy for Overactive Bladder
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
rTMS in Overactive Bladder
The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
TReating Incontinence for Underlying Mental and Physical Health
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Turkish USIQ: Validity & Reliability
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women
Percutaneous Nerve Evaluation Trial Time
Mirabegron in Patients With Age-Related Macular Degeneration
Usability Study of the FemPulse System